triiodothyronine has been researched along with beraprost in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Mackenzie, LS; Patel, P; Perez Diaz, N; Zloh, M | 1 |
2 other study(ies) available for triiodothyronine and beraprost
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In silico modelling of prostacyclin and other lipid mediators to nuclear receptors reveal novel thyroid hormone receptor antagonist properties.
Topics: Animals; Binding, Competitive; Computer Simulation; Dose-Response Relationship, Drug; Epoprostenol; Humans; Ligands; Male; Mesenteric Arteries; Models, Molecular; Myography; Protein Domains; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Receptors, Thyroid Hormone; Thiazoles; Thyroid Hormone Receptors alpha; Thyroid Hormone Receptors beta; Triiodothyronine; Vasodilation | 2016 |